It might be tempting to relax after the easing of Hong Kong’s anti-pandemic measures, but the flu outbreak in China shows we must remain vigilant. This is a chance to set good practices to prepare for future pandemics, strengthen our healthcare system and establish the city as a biomedical innovation hub.
A pro-innovation healthcare system and favourable business environment could persuade multinational biotech companies to put more resources into Hong Kong. Collaboration is paramount and the Greater Bay Area should aim to be a pioneer in China.